EUVIMEDEUVIMED entdecken
Crossref

Cisplatin-Based Chemotherapy Eligibility: Discrepancy Between Serum Creatinine Level and Glomerular Filtration Rate

Kambiz Novin, Shiva Moghadam, Nafiseh Mortazavi, Farnaz Hosseini Kamal, Helaleh Khoshbakht Ahmadi, Ahamd Ameri

Reports of Radiotherapy and Oncology · 2015

DOI: 10.17795/rro-3093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reports of Radiotherapy and Oncology, 2015. Verfasst von Kambiz Novin und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Novin, K., Moghadam, S., Mortazavi, N., Kamal, F. H., Ahmadi, H. K., & Ameri, A. (2015). Cisplatin-Based Chemotherapy Eligibility: Discrepancy Between Serum Creatinine Level and Glomerular Filtration Rate. Reports of Radiotherapy and Oncology. https://doi.org/10.17795/rro-3093

Vancouver

Novin K, Moghadam S, Mortazavi N, Kamal FH, Ahmadi HK, Ameri A. Cisplatin-Based Chemotherapy Eligibility: Discrepancy Between Serum Creatinine Level and Glomerular Filtration Rate. Reports of Radiotherapy and Oncology. 2015. doi:10.17795/rro-3093

BibTeX
@article{Novin2015,
  author = {Novin, Kambiz and Moghadam, Shiva and Mortazavi, Nafiseh and Kamal, Farnaz Hosseini and Ahmadi, Helaleh Khoshbakht and Ameri, Ahamd},
  title = {Cisplatin-Based Chemotherapy Eligibility: Discrepancy Between Serum Creatinine Level and Glomerular Filtration Rate},
  journal = {Reports of Radiotherapy and Oncology},
  year = {2015},
  doi = {10.17795/rro-3093}
}
Kostenlos starten →